Title : Effects of genetic polymorphisms on the OCT1 and OCT2-mediated uptake of ranitidine.

Pub. Date : 2017

PMID : 29236753






13 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Ranitidine was reported to be a substrate of the organic cation transporters OCT1 and OCT2. Ranitidine solute carrier family 22 member 1 Homo sapiens
2 AIM: In this study we analyzed the effects of genetic polymorphisms in OCT1 and OCT2 on the uptake of ranitidine and on its potency to inhibit uptake of other drugs. Ranitidine solute carrier family 22 member 1 Homo sapiens
3 METHODS AND RESULTS: We characterized ranitidine uptake using HEK293 and CHO cells stably transfected to overexpress wild type OCT1, OCT2, or their naturally occurring allelic variants. Ranitidine solute carrier family 22 member 1 Homo sapiens
4 Ranitidine was transported by wild-type OCT1 with a Km of 62.9 muM and a vmax of 1125 pmol/min/mg protein. Ranitidine solute carrier family 22 member 1 Homo sapiens
5 Alleles OCT1*5, *6, *12, and *13 completely lacked ranitidine uptake. Ranitidine solute carrier family 22 member 1 Homo sapiens
6 The effects of OCT1 alleles on ranitidine uptake strongly correlated with the effects on morphine uptake suggesting common interaction mechanisms of both drugs with OCT1. Ranitidine solute carrier family 22 member 1 Homo sapiens
7 The effects of OCT1 alleles on ranitidine uptake strongly correlated with the effects on morphine uptake suggesting common interaction mechanisms of both drugs with OCT1. Ranitidine solute carrier family 22 member 1 Homo sapiens
8 Ranitidine inhibited the OCT1-mediated uptake of metformin and morphine at clinically relevant concentrations. Ranitidine solute carrier family 22 member 1 Homo sapiens
9 CONCLUSIONS: We confirmed ranitidine as an OCT1 substrate and demonstrated that common genetic polymorphisms in OCT1 strongly affect ranitidine uptake and modulate ranitidine"s potential to cause drug-drug interactions. Ranitidine solute carrier family 22 member 1 Homo sapiens
10 CONCLUSIONS: We confirmed ranitidine as an OCT1 substrate and demonstrated that common genetic polymorphisms in OCT1 strongly affect ranitidine uptake and modulate ranitidine"s potential to cause drug-drug interactions. Ranitidine solute carrier family 22 member 1 Homo sapiens
11 CONCLUSIONS: We confirmed ranitidine as an OCT1 substrate and demonstrated that common genetic polymorphisms in OCT1 strongly affect ranitidine uptake and modulate ranitidine"s potential to cause drug-drug interactions. Ranitidine solute carrier family 22 member 1 Homo sapiens
12 CONCLUSIONS: We confirmed ranitidine as an OCT1 substrate and demonstrated that common genetic polymorphisms in OCT1 strongly affect ranitidine uptake and modulate ranitidine"s potential to cause drug-drug interactions. Ranitidine solute carrier family 22 member 1 Homo sapiens
13 The effects of the frequent OCT1 polymorphisms on ranitidine pharmacokinetics in humans remain to be analyzed. Ranitidine solute carrier family 22 member 1 Homo sapiens